To report a methodology for the construction of supramolecular architectures to obtain isostructural compounds through the diversion of the structures, a series of mercury complexes containing N-(3-halophenyl)-2-pyridinecarboxamide ligands, have been synthesized for a systematic.
Acalabrutinib, an anti-cancer drug, was approved by the USFDA in 2017.
Supramolecular assemblies of 4-cyanophenylboronic acid with various N-donor compounds having different conformational features developed exotic networks in the crystal lattices in the form of stacked layers, helical chains, and crossed ribbons.
Nine R-[1,2,5]oxadiazolo[3,4-c]cinnoline oxides were obtained, and the efficiency of 14N NMR in detecting compounds was demonstrated. Variation in substituents at different positions leads to partial isostructurality of the crystal structures.
C hydrogen bonded dimer structures
Hydrogenation of two 4-acetylsydnones led to an isostructural pair of hydrogen bonded O–H⋯O
C dimers strengthening the sydnone–sydnone supramolecular synthon formed by two antiparallel sydnone rings.